GILEAD SCIENCES, INC. - 23 Feb 2026 SCHEDULE 13D Report for Arcellx, Inc. Common Stock, par value $0.001 (ACLX)

Filing Manager: GILEAD SCIENCES, INC.
Reporting Manager: Gilead Sciences, Inc.
Security: Arcellx, Inc. Common Stock, par value $0.001
Symbol: ACLX
Shares outstanding: 58,441,765 shares
Disclosed Ownership: 6,720,803 shares
Ownership: 12%
Form type: SCHEDULE 13D
Filing time: 23 Feb 2026, 06:51:54 UTC
Date of event: 23 Feb 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Gilead Sciences, Inc.	12%	6,720,803	6,720,803	0	/s/ Andrew D. Dickinson	Andrew D. Dickinson/Chief Financial Officer	0000882095